• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生命科学领域的产学关系。范围、影响及管理。

Academic-industry relationships in the life sciences. Extent, consequences, and management.

作者信息

Blumenthal D

机构信息

Health Policy Research and Development Unit, Massachusetts General Hospital, Boston 02114.

出版信息

JAMA. 1992 Dec 16;268(23):3344-9.

PMID:1453527
Abstract

Academic-industry relationships in the life sciences remain controversial. The available evidence suggests that such relationships have both benefits and risks for involved parties. Benefits include additional support of academic research, income for academic health centers, the potential for increased scientific and commercial productivity in both industries and universities, and enhancement of the educational experiences of students and fellows. Risks include an increase in secrecy in academic environments and damage to public support for the life science enterprise. The balance of known benefits and risks suggests that academic-industry relationships should be permitted and even selectively promoted. However, there is also a need for enhanced vigilance on the part of academic institutions and government to reduce risks posed by certain types of arrangements, especially those involving human subjects. Enhanced vigilance should include disclosure of all academic-industry relationships by life science faculty.

摘要

生命科学领域的学术-产业关系仍然存在争议。现有证据表明,这种关系对相关各方既有好处也有风险。好处包括对学术研究的额外支持、学术健康中心的收入、增加产业界和大学科研及商业产出的潜力,以及提升学生和研究员的教育体验。风险包括学术环境中保密性增强以及公众对生命科学事业支持度受损。已知的好处与风险的权衡表明,学术-产业关系应该被允许,甚至有选择地加以促进。然而,学术机构和政府也需要提高警惕,以降低某些类型安排带来的风险,尤其是涉及人体受试者的那些安排。加强警惕应包括生命科学教员披露所有学术-产业关系。

相似文献

1
Academic-industry relationships in the life sciences. Extent, consequences, and management.生命科学领域的产学关系。范围、影响及管理。
JAMA. 1992 Dec 16;268(23):3344-9.
2
Ethics issues in academic-industry relationships in the life sciences: the continuing debate.生命科学领域学术与产业关系中的伦理问题:持续的争论
Acad Med. 1996 Dec;71(12):1291-6. doi: 10.1097/00001888-199612000-00010.
3
Relationships between academic institutions and industry in the life sciences--an industry survey.生命科学领域学术机构与产业界的关系——一项产业调查
N Engl J Med. 1996 Feb 8;334(6):368-73. doi: 10.1056/NEJM199602083340606.
4
Participation of life-science faculty in research relationships with industry.生命科学领域教师参与与产业界的研究合作关系。
N Engl J Med. 1996 Dec 5;335(23):1734-9. doi: 10.1056/NEJM199612053352305.
5
Institutional academic industry relationship: results of interviews with university leaders.机构的学术与行业关系:对大学领导的访谈结果
Account Res. 2004 Apr-Jun;11(2):103-18. doi: 10.1080/03050620490512296.
6
Perception, reality, and the political context of conflict of interest in university-industry relationships.大学-产业关系中利益冲突的认知、现实与政治背景。
Acad Med. 1996 Dec;71(12):1297-304. doi: 10.1097/00001888-199612000-00011.
7
Academic industry relationships in biotechnology: a primer on policy and practice.生物技术领域的学术-产业关系:政策与实践入门
Cloning. 2000;2(3):129-36. doi: 10.1089/152045500750039833.
8
From genes to therapeutics: educating the government and the public on biomedical sciences-a Singapore experience.从基因到疗法:向政府和公众普及生物医学科学——新加坡的经验
Bioessays. 2003 Sep;25(9):913-7. doi: 10.1002/bies.10346.
9
Academic-industrial relationships in the life sciences.生命科学领域的学术-产业关系。
N Engl J Med. 2003 Dec 18;349(25):2452-9. doi: 10.1056/NEJMhpr035460.
10
Looking a gift horse in the mouth: corporate gifts supporting life sciences research.对礼物吹毛求疵:支持生命科学研究的企业礼品
JAMA. 1998 Apr 1;279(13):995-9. doi: 10.1001/jama.279.13.995.

引用本文的文献

1
Benchmarks for ethically credible partnerships between industry and academic health centers: beyond disclosure of financial conflicts of interest.行业与学术健康中心之间符合道德规范的可信合作关系的基准:超越财务利益冲突的披露
Clin Transl Med. 2015 Dec;4(1):36. doi: 10.1186/s40169-015-0077-y. Epub 2015 Dec 14.
2
Evidence-based ethics for neurology and psychiatry research.神经病学与精神病学研究的循证伦理学
NeuroRx. 2004 Jul;1(3):372-7. doi: 10.1602/neurorx.1.3.372.
3
The commercialization of clinical genetics: an analysis of interrelations between academic centers and for-profit clinical genetics diagnostics companies.
临床遗传学的商业化:学术中心与营利性临床遗传学诊断公司之间的相互关系分析。
J Genet Couns. 1997 Sep;6(3):337-55. doi: 10.1023/a:1025632423186.
4
Patenting human genetic material: refocusing the debate.人类遗传物质的专利问题:重新聚焦辩论
Nat Rev Genet. 2000 Dec;1(3):227-31. doi: 10.1038/35042087.
5
Commercialisation of genetic diagnostic services.
Med Health Care Philos. 1998;1(3):217-24. doi: 10.1023/a:1009913008908.
6
The value of commercial funding in health services research: the case of the APACHE III methodology.商业资金在卫生服务研究中的价值:以急性生理学及慢性健康状况评分系统III(APACHE III)方法为例。
Health Serv Res. 1994 Feb;28(6):673-8; discussion 683-7.